DE69838300D1 - Pharmazeutische suspensionstabletten-zusammenstellungen - Google Patents

Pharmazeutische suspensionstabletten-zusammenstellungen

Info

Publication number
DE69838300D1
DE69838300D1 DE69838300T DE69838300T DE69838300D1 DE 69838300 D1 DE69838300 D1 DE 69838300D1 DE 69838300 T DE69838300 T DE 69838300T DE 69838300 T DE69838300 T DE 69838300T DE 69838300 D1 DE69838300 D1 DE 69838300D1
Authority
DE
Germany
Prior art keywords
percent
tablets
microcrystalline cellulose
tablet compositions
pharmaceutical suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69838300T
Other languages
English (en)
Other versions
DE69838300T2 (de
Inventor
Michael Augello
Sheila M Dell
George A Agyilirah
George E Reier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FMC Corp
Original Assignee
FMC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FMC Corp filed Critical FMC Corp
Publication of DE69838300D1 publication Critical patent/DE69838300D1/de
Application granted granted Critical
Publication of DE69838300T2 publication Critical patent/DE69838300T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
DE69838300T 1997-12-12 1998-11-20 Pharmazeutische suspensionstabletten-zusammenstellungen Expired - Fee Related DE69838300T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/989,787 US5955107A (en) 1997-12-12 1997-12-12 Pharmaceutical suspension tablet compositions
US989787 1997-12-12
PCT/US1998/024798 WO1999030689A1 (en) 1997-12-12 1998-11-20 Pharmaceutical suspension tablet compositions

Publications (2)

Publication Number Publication Date
DE69838300D1 true DE69838300D1 (de) 2007-10-04
DE69838300T2 DE69838300T2 (de) 2008-05-15

Family

ID=25535456

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69838300T Expired - Fee Related DE69838300T2 (de) 1997-12-12 1998-11-20 Pharmazeutische suspensionstabletten-zusammenstellungen

Country Status (7)

Country Link
US (1) US5955107A (de)
EP (1) EP1035838B1 (de)
AT (1) ATE370727T1 (de)
AU (1) AU1531199A (de)
DE (1) DE69838300T2 (de)
ES (1) ES2293694T3 (de)
WO (1) WO1999030689A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
ES2277682T3 (es) * 1998-06-11 2007-07-16 PHARMACIA & UPJOHN COMPANY LLC Formulacion de delavirdina en comprimido.
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
GT200100039A (es) * 2000-03-16 2001-12-31 Pfizer Inhibidor de la glucogeno fosforilasa.
AU2001261744A1 (en) * 2000-05-19 2001-12-03 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
CN1688291A (zh) * 2002-02-01 2005-10-26 辉瑞产品公司 含有固体药物分散体的即刻释放剂型
CN1681497A (zh) * 2002-07-16 2005-10-12 兰贝克赛实验室有限公司 口服给药用的可分散片剂
US20070014850A1 (en) * 2002-08-02 2007-01-18 Ramalingam Manikandan Process for the preparation of dispersible tablets of cephalexin
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US20040161459A1 (en) * 2002-12-31 2004-08-19 Ngoc Do Fast-dissolve tablet technology
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7838029B1 (en) 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
CA2642761A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
AU2010300641B2 (en) * 2009-09-30 2016-03-17 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US9101636B2 (en) 2012-11-30 2015-08-11 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
WO2014102802A1 (en) 2012-12-30 2014-07-03 Hadasit Medical Research Services And Development Ltd. Alginate compositions and uses thereof
AU2015237723B2 (en) 2014-03-26 2018-04-26 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
WO2023101951A1 (en) * 2021-12-03 2023-06-08 Hercules Llc An organic chewable composition comprising certified organic ingredients, and process for preparing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7084587A (en) * 1986-04-01 1987-10-20 Upjohn Company, The Methylprednisolone/sodium carboxymethyl starch tablet composition
US4965072A (en) * 1988-11-03 1990-10-23 Miles Inc. Granulating composition and method
US5073377A (en) * 1988-11-03 1991-12-17 Miles Inc. Method of preparing oral dosage forms with a granulating composition
SK282072B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta s obsahom lamotrigínu dispergovateľná vo vode a spôsob jej prípravy
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CA2205442C (en) * 1994-12-01 2003-01-21 David R. Friend Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
US5858409A (en) * 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals

Also Published As

Publication number Publication date
EP1035838B1 (de) 2007-08-22
EP1035838A4 (de) 2006-01-18
ES2293694T3 (es) 2008-03-16
ATE370727T1 (de) 2007-09-15
EP1035838A1 (de) 2000-09-20
WO1999030689A1 (en) 1999-06-24
AU1531199A (en) 1999-07-05
DE69838300T2 (de) 2008-05-15
US5955107A (en) 1999-09-21

Similar Documents

Publication Publication Date Title
ATE370727T1 (de) Pharmazeutische suspensionstabletten- zusammenstellungen
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
ATE209898T1 (de) Feste arzneizubereitung
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
NO20065390L (no) Farmasoytisk preparat i fast enhetsdoseringsform
FI20011852A (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
HUP0004383A3 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
NZ322053A (en) Controlled release pharmaceutical formulation comprising an active, a low MW polyethylene oxide, HPMC and one or more enteric polymers
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
MY104010A (en) Pharmaceutical compositions.
CA2330480A1 (en) Controlled release formulation of divalproex sodium
ATE391495T1 (de) Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
RU96116411A (ru) Быстро распадающаяся готовая препаративная форма трамадола или соли трамадола
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
CA2229283A1 (en) Prednisolone metasulphobenzoate preparation for the treatment of inflammatory bowel disease
HUP9801241A2 (hu) Vastagbélbe beadható, azathioprine tartalmú készítmények és eljárás előállításukra
SE8901003L (sv) Snabbloesliga preparat
EA200401418A1 (ru) Способ получения таблеток из фармацевтически активных веществ, имеющих неблагоприятные свойства для таблетирования, с использованием гранулирующей жидкости, содержащей микрокристаллическую целлюлозу
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
YU47044B (sh) Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
HUP9903410A2 (hu) Tolfenámsavat vagy gyógyszerészetileg elfogadható sóját tartalmazó, gyors hatóanyag-leadású tabletta

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee